References
- Kanmani, P., Satish Kumar, R., Yuvaraj, N., Paari, K.A., Pattukumar, V. and Arul, V.: Probiotics and its functionally valuable products-a review. Crit. Rev. Food Sci. Nutr. 53, 641-658 (2013). https://doi.org/10.1080/10408398.2011.553752
- An, H.M., Baek, E.H., Jang, S., Lee, D.K., Kim, M.J., Kim, J.R., Lee, K.O., Park, J.G. and Ha, N.J.: Efficacy of lactic acid bacteria (LAB) supplement in management of constipation among nursing home residents. Nutr. J. 9, 5 (2010). https://doi.org/10.1186/1475-2891-9-5
- Pattani, R., Palda, V.A., Hwang, S.W. and Shah, P.S.: Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis. Open Med. 7, e56-67 (2013).
- Tsai, Y.T., Cheng, P.C. and Pan, T.M.: The immunomodulatory effects of lactic acid bacteria for improving immune functions and benefits. Appl. Microbiol. Biotechnol. 96, 853-862 (2012). https://doi.org/10.1007/s00253-012-4407-3
- Zhong, L., Zhang, X. and Covasa, M.: Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J. Gastroenterol. 20, 7878-7886 (2014). https://doi.org/10.3748/wjg.v20.i24.7878
- Kumar, M., Nagpal, R., Kumar, R., Hemalatha, R., Verma, V., Kumar, A., Chakraborty, C., Singh, B., Marotta, F., Jain, S. and Yadav, H.: Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp. Diabetes Res. 2012, 902917 (2012).
- Capozzi, V., Russo, P., Duenas, M.T., Lopez, P. and Spano, G.: Lactic acid bacteria producing B-group vitamins: a great potential for functional cereals products. Appl. Microbiol. Biotechnol. 96, 1383-1394 (2012). https://doi.org/10.1007/s00253-012-4440-2
- Saez-Lara, M.J., Gomez-Llorente, C., Plaza-Diaz, J. and Gil, A.: The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed. Res. Int. 2015, 505878 (2015).
- Rastall, R.A.: Functional oligosaccharides: application and manufacture. Annu. Rev. Food Sci. Technol. 1, 305-339 (2010). https://doi.org/10.1146/annurev.food.080708.100746
- Isawa, K., Hojo, K., Yoda, N., Kamiyama, T., Makino, S., Saito, M., Sugano, H., Mizoguchi, C., Kurama, S., Shibasaki, M., Endo, N. and Sato, Y.: Isolation and identification of a new bifidogenic growth stimulator produced by Propionibacterium freudenreichii ET-3. Biosci. Biotechnol. Biochem. 66, 679-681 (2002). https://doi.org/10.1271/bbb.66.679
- Nagata, K., Inatsu, S., Tanaka, M., Sato, H., Kouya, T., Taniguchi, M. and Fukuda, Y.: The bifidogenic growth stimulator inhibits the growth and respiration of Helicobacter pylori. Helicobacter 15, 422-429 (2010). https://doi.org/10.1111/j.1523-5378.2010.00789.x
- Song, Y.G.: Overview of Helicobacter pylori and treatment options. Econ. Environ. Geol. 48, 241-246 (2015). https://doi.org/10.9719/EEG.2015.48.3.241
- Kang, J.E., Kim, T.J. and Moon, G.S.: A novel Lactobacillus casei LP1 producing 1,4-dihydroxy-2-naphthoic acid, a bifidogenic growth stimulator. Prev. Nutr. Food Sci. 20, 78-81 (2015). https://doi.org/10.3746/pnf.2015.20.1.78
- Rokka, S., Pihlanto, A., Korhonen, H. and Joutsjoki, V.: In vitro growth inhibition of Helicobacter pylori by lactobacilli belonging to the Lactobacillus plantarum group. Lett. Appl. Microbiol. 43, 508-513 (2006). https://doi.org/10.1111/j.1472-765X.2006.01998.x
- Sunanliganon, C., Thong-Ngam, D., Tumwasorn, S. and Klaikeaw, N.: Lactobacillus plantarum B7 inhibits Helicobacter pylori growth and attenuates gastric inflammation. World J. Gastroenterol. 18, 2472-2480 (2012). https://doi.org/10.3748/wjg.v18.i20.2472